DOSING REGIMENS FOR USE WITH PCSK9 INHIBITORS

Number of patents in Portfolio can not be more than 2000

United States of America

APP PUB NO 20200024364A1
SERIAL NO

16415837

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides methods for treating a PCSK9-mediated disease or a PCSK9-mediated condition. Specifically, the invention relates to methods comprising the administration of a proprotein convertase subtilisin/kexin type 9 (PCSK9) antibody or antigen binding protein, in the absence of a statin, to a subject in need thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
REGENERON PHARMACEUTICALS INC777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baccara-Dinet, Marie Paris, FR 9 86
Bessac, Laurence Paris, FR 20 236
Hanotin, Corinne Paris, FR 24 256
Pordy, Robert C Tarrytown, US 27 337
Rey, Jacques Paris, FR 11 175
Sasiela, William J Tarrytown, US 27 377

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation